• NVP-BGJ398 Phosphate for Reliable FGFR Assays

  2026-08-10

  Learn how NVP-BGJ398 phosphate, SKU A3673, can improve experimental consistency in FGFR-driven viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects formulation, assay design, pathway validation, and evidence from cancer and skeletal-disease models.

• SIS3 (Smad3 Inhibitor) in Fibrosis Research

  2026-08-09

  SIS3 is a selective Smad3 inhibitor for dissecting TGF-β signaling in cellular and animal research. Product documentation describes pathway-selective effects, fibrosis-related activity, and preclinical use, while independent literature supports canonical TGF-β/SMAD3 signaling as a disease-relevant axis in lung adenocarcinoma.

• GPCR Control of Kir7.1 Glycosylation and Activity

  2026-08-08

  Carrington et al. show that GPCRs regulate Kir7.1 through a mechanism distinct from the canonical Gβγ-mediated control of GIRK channels: most receptors tested reduce complex glycosylation and channel activity without reducing surface abundance. Site-directed mutagenesis and analysis of the disease-associated L241P variant link Kir7.1 glycosylation to conductance and open probability, providing a mechanistic framework for studying channel dysfunction in retinal and other excitable tissues.

• WY-14643 Workflow for PPARα Research

  2026-08-07

  Build reproducible PPARα experiments with WY-14643 (Pirinixic Acid), from solubility-controlled cell assays to metabolic and endothelial readouts. The workflow also shows how to test the emerging PPARα–TF axis identified in pulmonary lymphoepithelioma-like carcinoma research without overstating translational evidence.

• Piezo1 Triggers PANoptosis in Cardiac Ischaemia/Reperfusion

  2026-08-07

  This study demonstrates that the mechanosensitive ion channel Piezo1 is a key driver of myocardial ischaemia/reperfusion (I/R) injury by activating caspase-8-mediated PANoptosis in cardiomyocytes. The findings identify Piezo1 as a novel mechanosensor linking mechanical stress to complex cell death pathways, highlighting a promising therapeutic target for ischaemic heart disease.

• Nutlin-3a (SKU A3671): Reliable MDM2 Inhibitor for Cancer Re

  2026-08-06

  This article provides a scenario-driven, evidence-based guide to using Nutlin-3a (SKU A3671) in cell viability, proliferation, and apoptosis assays. By contextualizing real-world laboratory challenges, it demonstrates how Nutlin-3a’s validated performance and workflow compatibility support reproducible, data-backed cancer research outcomes.

• DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution

  2026-08-06

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a straightforward approach for nuclear visualization, cell viability assessment, and apoptosis detection in fixed or membrane-compromised cells. It should not be used for live-cell imaging due to its limited cell permeability, but is optimized for use in fluorescence microscopy and flow cytometry protocols.

• Bufalin: Mechanisms and Benchmarks in Cancer Research

  2026-08-05

  Bufalin is a cardiotonic steroid that induces apoptosis and cell differentiation in cancer cells, notably via AP-1 activation pathways. As a molecular glue degrader of estrogen receptor alpha and a validated STK33 inhibitor, Bufalin demonstrates potent activity in triple-negative breast cancer models. This dossier details its mechanisms, evidence, and research utility.

• Trelagliptin succinate (SKU A3889): Reliable Solutions for D

  2026-08-05

  This scenario-driven guide demonstrates how Trelagliptin succinate (SKU A3889) addresses laboratory challenges in diabetes mellitus research, osteoblastic differentiation, and cytotoxicity workflows. Drawing on validated data and peer-reviewed studies, it provides practical, evidence-based recommendations for assay optimization and vendor selection. Researchers can rely on APExBIO’s Trelagliptin succinate for reproducibility and data integrity across diverse experimental models.

• Axitinib (AG 013736): Precision Tools for Angiogenesis Assay

  2026-08-04

  Axitinib (AG 013736) delivers unmatched selectivity and potency for dissecting VEGF signaling in cancer biology research. Explore protocol-driven workflows, troubleshooting insights, and practical guidance for maximizing reproducibility in angiogenesis and tumor growth inhibition studies.

• Viperin Inhibits Coronavirus Replication by Disrupting nsp8–

  2026-08-04

  This study uncovers a conserved mechanism by which the interferon-induced enzyme viperin restricts coronavirus replication. By targeting non-structural protein 8 (nsp8) and disrupting the assembly of the replication-transcription complex, viperin impairs viral RNA synthesis, revealing new antiviral intervention points and clarifying the dual role of viperin in both ddhCTP production and direct RTC inhibition.

• Phos binding reagent (Phosbind) acrylamide: Reliable Phospho

  2026-08-03

  This article addresses key workflow challenges in phosphorylation analysis, demonstrating how Phos binding reagent (Phosbind) acrylamide (SKU F4002) streamlines SDS-PAGE detection of phosphorylated proteins without the need for antibodies. Scenario-driven guidance, protocol parameters, and literature-backed advice highlight its reliability and practical value for biomedical researchers.

• Viral Targeting of RIPK3 Regulates Necroptosis and Inflammat

  2026-08-03

  The referenced study identifies a viral mechanism whereby orthopoxviruses, such as cowpox virus, induce proteasomal degradation of the necroptosis adaptor RIPK3 to suppress host inflammatory responses. This finding clarifies how viral inhibitors modulate cell death pathways, with significant implications for understanding virus-induced pathogenesis and immune evasion.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Optimizing Dual Reporter mR

  2026-08-02

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines Cy5 fluorescence and EGFP expression to streamline mRNA delivery, tracking, and translation efficiency in advanced gene regulation workflows. Its immune-evasive chemistry and dual-reporter design empower direct, quantitative cellular analysis that surpasses conventional single-label systems.

• Ciprofloxacin Hydrochloride: Mechanism, Evidence, and Resear

  2026-08-01

  Ciprofloxacin hydrochloride is a fluoroquinolone antibiotic with proven efficacy as a bacterial DNA replication inhibitor and immunomodulatory agent. Its benchmarked activity underpins FDA-approved anthrax treatment and advanced research on apoptosis modulation. This article details its mechanism, evidence, and research integration.

8047 records 4/537 page Previous Next 12345 下5页 Last page